Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (151-160 of 1,725) with videos related to

Pageof 173
Sort By:
Expert Opinion on Drug Safety|December 9, 2014
Safety of off-label biologicals in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Nature Reviews. Drug Discovery|March 2, 2012
Inflammatory bone loss: pathogenesis and therapeutic interventionKurt Redlich, Josef S Smolen
Nature Reviews. Rheumatology|February 4, 2011
Rheumatoid arthritis in 2010: from the gut to the jointClemens Scheinecker, Josef S Smolen
Reumatologia Clinica|November 18, 2011
Treating rheumatoid arthritis to target: evidence-based recommendations for enhanced disease managementMonika Schoels, Josef S Smolen
Annals of the Rheumatic Diseases|August 4, 2017
Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis managementRoberto Caporali, Josef S Smolen
Current Rheumatology Reports|November 12, 2003
Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeuticsDaniel Aletaha, Josef S Smolen
Arthritis and Rheumatism|April 16, 2002
Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysisDaniel Aletaha, Josef S Smolen
Rheumatic Diseases Clinics of North America|December 8, 2009
The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical careDaniel Aletaha, Josef S Smolen
Rheumatology (Oxford, England)|September 23, 2000
Efficacy and safety of leflunomide in active rheumatoid arthritisJ S Smolen, P Emery
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 5, 2002
Self-care agency and quality of life among adults diagnosed with inflammatory bowel diseaseD M Smolen, R Topp
Pageof 173

Showing results (151-160 of 1,725) with videos related to

Sort By:
Pageof 173
Expert Opinion on Drug Safety|December 9, 2014
Safety of off-label biologicals in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Nature Reviews. Drug Discovery|March 2, 2012
Inflammatory bone loss: pathogenesis and therapeutic interventionKurt Redlich, Josef S Smolen
Nature Reviews. Rheumatology|February 4, 2011
Rheumatoid arthritis in 2010: from the gut to the jointClemens Scheinecker, Josef S Smolen
Reumatologia Clinica|November 18, 2011
Treating rheumatoid arthritis to target: evidence-based recommendations for enhanced disease managementMonika Schoels, Josef S Smolen
Annals of the Rheumatic Diseases|August 4, 2017
Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis managementRoberto Caporali, Josef S Smolen
Current Rheumatology Reports|November 12, 2003
Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeuticsDaniel Aletaha, Josef S Smolen
Arthritis and Rheumatism|April 16, 2002
Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysisDaniel Aletaha, Josef S Smolen
Rheumatic Diseases Clinics of North America|December 8, 2009
The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical careDaniel Aletaha, Josef S Smolen
Rheumatology (Oxford, England)|September 23, 2000
Efficacy and safety of leflunomide in active rheumatoid arthritisJ S Smolen, P Emery
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 5, 2002
Self-care agency and quality of life among adults diagnosed with inflammatory bowel diseaseD M Smolen, R Topp
Pageof 173